companydata.dkcompanydata.dk

NORDIC PHARMACEUTICALS ApS: Financial statements 2021

CVR: 27430015

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 652,991 and a net result of DKK 71,351 compared with DKK 57,931 the year before. That is an increase of 8.5% compared with the year before. Equity in the 2021 report amounted to DKK 1,418,720. The solvency ratio was 54.5%. The company had 2 employees in the financial year.

Gross Profit
DKK 652,991
Profit/Loss
DKK 71,351
Equity
DKK 1,418,720
Total Assets
DKK 2,604,736
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-653K71K1.4M2
2020-602K58K1.3M3
2019-1.3M26K1.3M3
2018-1.1M34K1.3M3
2017-1M40K1.2M3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like NORDIC PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

NORDIC PHARMACEUTICALS ApS: The 2020 annual report is outJul 14, 2021

NORDIC PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK 602,014, and the net result was DKK 57,931.

About NORDIC PHARMACEUTICALS ApS

NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The board consists of Knud Benny Junge (chair). The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -165,886 and a net result of DKK -573,072 compared with DKK -2,664,416 the year before. Equity in the 2025 report amounted to DKK -1,725,613.

Source: annual report 2025, Danish Business Authority